Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
12.14
+0.13 (1.08%)
At close: May 13, 2026, 4:00 PM EDT
12.01
-0.13 (-1.07%)
After-hours: May 13, 2026, 7:59 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $14.16 million as of May 13, 2026. Its market cap has increased by 9.47% in one year.
Market Cap
14.16M
Enterprise Value
5.37M
1-Year Change
9.47%
Ranking
Category
Stock Price
$12.14
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $14.16M, a decrease of -92.82%. That is a compound annual growth rate of -40.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 14.16M | 50.31% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 14.77M |
| Genenta Science | 14.46M |
| Lexaria Bioscience | 14.30M |
| Vyome Holdings | 13.90M |
| Cyclerion Therapeutics | 13.44M |
| BioLineRx | 13.43M |
| Intensity Therapeutics | 12.93M |
| Phio Pharmaceuticals | 12.78M |